Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Clinical trial NCT00869401 · COMPLETED
Trial details
- NCT number
- NCT00869401
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2014-10-01
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.